Detection of suicidality from medical text using privacy-preserving large language models
- PMID: 39497458
- PMCID: PMC11669470
- DOI: 10.1192/bjp.2024.134
Detection of suicidality from medical text using privacy-preserving large language models
Abstract
Background: Attempts to use artificial intelligence (AI) in psychiatric disorders show moderate success, highlighting the potential of incorporating information from clinical assessments to improve the models. This study focuses on using large language models (LLMs) to detect suicide risk from medical text in psychiatric care.
Aims: To extract information about suicidality status from the admission notes in electronic health records (EHRs) using privacy-sensitive, locally hosted LLMs, specifically evaluating the efficacy of Llama-2 models.
Method: We compared the performance of several variants of the open source LLM Llama-2 in extracting suicidality status from 100 psychiatric reports against a ground truth defined by human experts, assessing accuracy, sensitivity, specificity and F1 score across different prompting strategies.
Results: A German fine-tuned Llama-2 model showed the highest accuracy (87.5%), sensitivity (83.0%) and specificity (91.8%) in identifying suicidality, with significant improvements in sensitivity and specificity across various prompt designs.
Conclusions: The study demonstrates the capability of LLMs, particularly Llama-2, in accurately extracting information on suicidality from psychiatric records while preserving data privacy. This suggests their application in surveillance systems for psychiatric emergencies and improving the clinical management of suicidality by improving systematic quality control and research.
Keywords: Large language models; electronic health records; natural language processing; psychiatric disorder detection; suicidality.
Conflict of interest statement
J.N.K. declares consulting services for Owkin, France, DoMore Diagnostics, Norway, Panakeia, UK, Scailyte, Switzerland, Cancilico, Germany, Mindpeak, Germany, MultiplexDx, Slovakia, and Histofy, UK; furthermore he holds shares in StratifAI GmbH, Germany, has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. I.C.W. received honoraria from AstraZeneca. U.L. participated in advisory boards and received honoraria by Janssen Cilag GmbH.
Figures


References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical